Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library REF English | Available | ||
c.2 BC Cancer Agency VAN Library REF Chinese | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr English | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr Chinese | Available | ||
c.3 BC Cancer Agency ARHCC Cancer Info Ctr French | Available | ||
c.4 BC Cancer Agency ARHCC Cancer Info Ctr Punjabi | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr English | Available | ||
c.2 BC Cancer Agency VAN Cancer Info Ctr Chinese | Available | ||
c.1 BC Cancer Agency VIC Library REF English | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
Strategy's priorities:; Priority 1 - Decrease the risk of people getting cancer.; Priority 2 - Diagnose cancer faster, accurately and at an earlier stage.; Priority 3 - Deliver high-quality care in a sustainable, world-class system.; Priority 4 - Eliminate barriers to people getting the care they n…
c.1 BC Cancer Agency VAN Library | Available |
Introduction; Chapitre 1: Le diagnostic; Chapitre 2: Le traitement; Chapitre 3: Les considérations financières; Chapitre 4: L'après-traitement; Chapitre 5: L'hérédité et les tests génétiques; Chapitre 6: Les récidives et les métastases; Chapitre 7: Les considérations juridiques; Chapitre 8: La prog…
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
The series is primarily intended to document the disease classifications used in the Population Health Impact of Disease in Canada (PHI) research program and help researchers to understand how the PHI estimates were calculated. It is also of interest to health professionals, advocacy groups, and in…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.3 BC Cancer Agency VIC Cancer Info Ctr | Available |
v.1: Mobilizing science and technology to Canada's advantage; v.2: Realiser le potentiel des sciences et de la technologie au profit du Canada; v.3: Mobilizing science and technology to Canada's advantage : summary
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans,; which met in Lyon, October 2013
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon (France) June 3 -10, 2014.
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans,; which met in Lyon, February 2013.
c.1 BC Cancer Agency VAN Library | Available |
This poster is an updated reproduction of "The smoker's body originally produced by COLORS magazine, issue 21, July-August 1997.
VC BC Cancer Agency VC Library Pamphlet File | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon , 3-10 June 2014.
c.1 BC Cancer Agency VAN Library | Available |